RE:RE:RE:RE:RE:RE:RE:Price on mondayQ1 is on the books now and will be out next month along with the AGM. We should see another good bump up in rev and a get a clearer picture of how the Aristotle plan is unfolding. A few people have wondered if the Q4 delay was intentional. But Szls has a history of messing QR's up so probably not a viable theory. I agree if things had happened in a different order Thursday may never have been a problem. Q4 a couple days early showing the $2.8m, a CC highlighting increasing rev and Aristotle shortly. Then Care Oncology NR this coming week. Whole different out come? Probably. But in reality we are still the same company with the same huge potential we always had.